Compare TRX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRX | STIM |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.2M | 105.5M |
| IPO Year | N/A | 2018 |
| Metric | TRX | STIM |
|---|---|---|
| Price | $0.89 | $1.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $1.25 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 01-14-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | $57,613,000.00 | ★ $129,873,000.00 |
| Revenue This Year | $93.43 | $101.67 |
| Revenue Next Year | $44.56 | $10.87 |
| P/E Ratio | $371.51 | ★ N/A |
| Revenue Growth | 39.98 | ★ 78.61 |
| 52 Week Low | $0.27 | $1.25 |
| 52 Week High | $1.02 | $5.92 |
| Indicator | TRX | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 55.15 | 45.13 |
| Support Level | $0.91 | $1.26 |
| Resistance Level | $1.02 | $1.44 |
| Average True Range (ATR) | 0.05 | 0.16 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 34.15 | 35.87 |
TRX Gold Corp is engaged in the exploration, development, and production of mineral property interests in the United Republic of Tanzania, focused on development and mining operations, and on exploring and evaluating its mineral properties. The business of exploring and mining for minerals involves a high degree of risk, and the underlying value of the mineral properties depends on the existence and economic recovery of mineral resources and reserves, as well as the ability to raise long-term financing to continue development. The company is focused on the Buckreef Gold Project, which comprises five prospects: Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba, and includes three main mineralized zones: Buckreef South, Buckreef Main, and Buckreef North.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.